Table 3: Open in new tab Observed...

Table 3:

Observed perioperative mortality and annual adverse events for all 215 DAH in young adults in comparison with reported results from Ross procedures, mechanical AVR and standard allograft implantation in young adults

	DAH	Ross^a	Mechanical^b	Bioprosthesis^c
Early death %	0.93	2.01	3.15	3.30
Late mortality %/y	0.29	0.59	1.55	2.39
Any reoperation and intervention %/y	0.95	1.20	0.51	1.82
Valve degeneration %/y	1.52	1.3	0.39	1.83
Thrombosis/bleeding %/y	0.19	0.30	1.89	0.82
Endocarditis %/y	0.48	0.27	0.41	0.48

	DAH	Ross^a	Mechanical^b	Bioprosthesis^c
Early death %	0.93	2.01	3.15	3.30
Late mortality %/y	0.29	0.59	1.55	2.39
Any reoperation and intervention %/y	0.95	1.20	0.51	1.82
Valve degeneration %/y	1.52	1.3	0.39	1.83
Thrombosis/bleeding %/y	0.19	0.30	1.89	0.82
Endocarditis %/y	0.48	0.27	0.41	0.48

Ross results include right ventricular procedures.

Data taken from Etnel et al. Circ Cardiovasc Qual Outcomes 2019;12:e005481.

Data taken from Korteland et al. Eur Heart J. 2017; 38:3370–7.

Data taken from Etnel et al. Circ Cardiovasc Qual Outcomes 2018;11:e004748.

This Feature Is Available To Subscribers Only